Latest Breaking News On - Bhatnagar anish - Page 1 : comparemela.com

Soleno Therapeutics (NASDAQ:SLNO) Trading Up 3 1%

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) were up 3.1% during trading on Wednesday . The company traded as high as $42.04 and last traded at $42.04. Approximately 65,481 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 360,998 shares. The stock had previously closed […]

Robertw bairdBhatnagar anishPiper sandlerMaven securitiesVivo capitalSecurities exchange commissionYork mellon corpVivo opportunity llcSoleno therapeutics incSilverarc capital managementSoleno therapeuticsGet free reportVivo opportunityExchange commissionNew york mellon corpCapital management

Soleno Therapeutics (NASDAQ:SLNO) Given New $59 00 Price Target at Oppenheimer

Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its price target cut by Oppenheimer from $65.00 to $59.00 in a research report report published on Monday, Benzinga reports. They currently have an outperform rating on the stock. A number of other research analysts also recently weighed in on SLNO. Stifel Nicolaus assumed coverage on shares of […]

Bhatnagar anishPiper sandlerRobertw bairdStifel nicolausYork mellon corpVivo opportunity llcSoleno therapeutics company profileSilverarc capital managementSoleno therapeutics incSecurities exchange commissionCarlyle group incVivo capitalMaven securitiesSoleno therapeuticsFree reportGet free report

Soleno Therapeutics (NASDAQ:SLNO) Upgraded to Strong-Buy at Baird R W

Soleno Therapeutics (NASDAQ:SLNO) Upgraded to Strong-Buy at Baird R W
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdStifel nicolausPiper sandlerBhatnagar anishSoleno therapeutics company profileCarlyle group incMaven securitiesVivo capitalSoleno therapeutics incYork mellon corpSilverarc capital managementSoleno therapeuticsFree reportGet free reportKristen yenNew york mellon corp

Soleno Therapeutics (NASDAQ:SLNO) Research Coverage Started at Robert W Baird

Soleno Therapeutics (NASDAQ:SLNO) Research Coverage Started at Robert W Baird
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerStifel nicolausRobertw bairdBhatnagar anishWalleye capitalVivo opportunity llcSchonfeld strategic advisorsSecurities exchange commissionSoleno therapeutics incCarlyle group incVivo capitalSilverarc capital managementSoleno therapeuticsGet free reportTherapeutics stock downVivo opportunity

Soleno Therapeutics, Inc (NASDAQ:SLNO) Given Consensus Rating of Buy by Analysts

Soleno Therapeutics, Inc (NASDAQ:SLNO) Given Consensus Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdPiper sandlerStifel nicolausBhatnagar anishVivo opportunity llcVivo capitalSoleno therapeutics company profileCarlyle group incSoleno therapeutics incSecurities exchange commissionSoleno therapeuticsGet free reportVivo opportunityExchange commissionCapital partnersPoint capital